khawla abu hammour
@ju.edu.jo
University of Jordan
Scopus Publications
- Cost Savings in Oncology Chemotherapy: The Role of Vial Sharing in Centralized Preparation
Khawla Abu Hammour, Alaa Almomani, Aya Allan, Mohammad Ballout, Mariam Abdel Jalil, Faris El-Dahiyat, Rana K. Abu-Farha
Value in Health Regional Issues, 2026 - Factors affecting pharmacy and medical students knowledge and attitude towards respiratory syncytial virus vaccines
Khawla Abu Hammour, Faris El-Dahiyat, Fahmi Y. Al-Ashwal, Qusai Manaseer, Walid Abu Hammour, Rana K. Abu-Farha
Currents in Pharmacy Teaching and Learning, 2026 - Health technology assessment in Jordan: current landscape, challenges, and future roadmap
Khawla Abu Hammour, Faris El-Dahiyat, Zaheer-Ud-Din Babar, Fahmi Y. Al-Ashwal, Rana K. Abu-Farha
Journal of Pharmaceutical Policy and Practice, 2026
Background: Health Technology Assessment (HTA) is increasingly recognised as an essential tool for directing decisions on health policy, particularly those concerning coverage, reimbursement, price and value, especially in nations aiming for Universal Health Coverage (UHC). Jordan is a middle-income country with limited resources for the health sector and rising needs; thus, despite its significant progress toward institutionalising HTA, there are still many gaps. Objectives: To assess the present situation of HTA in Jordan, pinpoint the main facilitators and obstacles, and suggest a plan for enhancing HTA at Jordan University Hospital so that it can more methodically influence Jordanian health policy. Methods: Stakeholder studies, policy documents and published literature on HTA were reviewed, along with lessons learned from similar contexts. Results: Jordan's progress in HTA has been noteworthy. The Jordan Food and Drug Administration has specific requirements for pharmacoeconomic data in pricing and reimbursement, for instance, and university programs are providing capacity building. Other pioneers include the Ministry of Health, Royal Medical Services and the King Hussein Cancer Center's Centre for Drug Policy and Technology Assessment (KHCC CDPTA). However, funding for HTA is unstable, transparency and stakeholder engagement are uneven, institutional roles are fragmented, there is no national HTA methodological guideline or comprehensive, mandated legal framework, and data infrastructure (especially local cost, outcomes and real-world evidence) is limited. Conclusions: A strategic plan is required for all institutions to achieve the potential benefits of HTA in Jordan, including more equitable access, better prioritisation, more efficient spending and contributions to UHC. Formalising legal requirements, creating national methodological guidelines, enhancing institutional and human capacity, enhancing data systems, obtaining long-term funding, establishing precise decision criteria and thresholds and boosting transparency and stakeholder participation are important stages. - Healthcare Applications of Artificial Intelligence
Faris El-Dahiyat, Meriam Alomari, Khawla Abu Hammour, Rima Heider Al Omari, Ghaleb El Refae
Lecture Notes in Networks and Systems, 2026 - Prevalence of diabetes distress and its association with medication adherence and diabetes control among patients with type 2 diabetes mellitus in Egypt and Jordan
Mohamed Hassan Elnaem, Muna Barakat, Merna Mahmoud Abou Khatwa, Khawla Abu-Hammour, Yasmeen Barakat, Rana Abu-Farha
Critical Public Health, 2026
This study aimed to examine the prevalence of diabetes distress and explore its potential impact on medication adherence and diabetes control. This cross-sectional clinical study was conducted among outpatients with type 2 diabetes in selected hospitals in Egypt and Jordan. The validated tools, the Diabetes Distress Scale (DSS), Self-Efficacy for Appropriate Medication Use (SEAMS), and the Malaysia Medication Adherence Assessment Tool (MyMAAT), were used for data collection. Descriptive and inferential statistics were employed as appropriate. This study included 475 participants, 56% from Egypt and 44% from Jordan. Among participants, 77.5% faced complications, and 45% exhibited uncontrolled HbA1c levels – a total of 29% and 40% experienced moderate and severe distress, respectively. The findings reveal a median total DSS score of 2.29 (IQR 1.41) on a scale of 1–6, with variations across subscales. Regimen distress had the highest score at 2.40 (IQR 1.60), followed by physician-related distress at 2.25 (IQR 1.75) and emotional distress at 2.20 (IQR 2.00). The interpersonal subscale recorded the lowest score at 2.00 (IQR 1.67). Spearman’s rank correlation coefficient was employed to assess the relationship between diabetes distress and medication adherence. A significant negative correlation was observed (rs = −0.339, p < 0.001), indicating that higher levels of diabetes distress are associated with lower medication adherence. Our study explored the potential relationship between diabetes distress and HbA1c-based diabetes control. The Mann-Whitney U test (U = 20613, p = 0.004) revealed a significant difference in total Diabetes Distress Scale (DDS) scores between the two groups. The mean ranks indicate that DDS scores are notably higher in the uncontrolled group (206.97) compared to the controlled group (174.40). Diabetes-related distress appears to be widespread and is associated with various patient-related factors. This distress can significantly influence medication adherence and overall diabetes control. Strategies to enhance diabetes control should prioritise interventions that address key distress domains, particularly regimen and physician-related challenges. - Carbapenem De-escalation in urinary tract infections: prevalence and outcomes among hospitalized patients
Leedia Abuelshayeb, Rana Abu-Farha, Khawla Abu Hammour, Mohammed Zawiah
BMC Infectious Diseases, 2025
OBJECTIVE: To evaluate the prevalence and outcomes of carbapenem de-escalation among hospitalized urinary tract infection (UTI) patients at Jordan University Hospital from January 2022 to March 2024. METHODS: This retrospective study included adult patients who received carbapenems as empirical therapy and underwent urine culture testing. Patients who were discharged before culture results (n = 31) were excluded. The primary outcome was to assess the rate of effective de-escalation, which is the transition to a narrower-spectrum antibiotic without therapeutic failure. Secondary outcomes included the effect on successful de-escalation on patients' hospital length of stay, and the relationship between urine culture results and the success of de-escalation. When determining whether to de-escalate, factors such as clinical stability, and urine culture results and susceptibility were considered. Chi-square test assessed associations between culture results and de-escalation success. RESULTS: A total of 205 patients who received carbapenems as empirical therapy and underwent urine culture testing were included in the study. Out of these, 116 individuals (56.6%) had negative culture results, indicating no infection, while 89 individuals (43.4%) tested positive, confirming the presence of an infection. Among these patients, 95.6% (196 out of 205) required de-escalation of their treatment, whereas 4.4% did not. The prevalence of successful de-escalation was 40.3% (79 out of 196). The analysis revealed that successful de-escalation is much more likely in cases with urine cultures showing growth (86.8%) compared to those with no growth (17.2%) (p = 0.001). The study also indicated no significant differences in the length of hospital stay between the successfully de-escalated group and those who failed or were incorrectly de-escalated (P > 0.05). CONCLUSIONS: The study underscores the challenges of implementing effective antibiotic stewardship in UTI management, particularly regarding carbapenem de-escalation. Enhanced protocols and clinician education are essential to optimize de-escalation practices, especially in cases with negative microbiological results. Further research is needed to refine these strategies and address the growing issue of antibiotic resistance in UTIs. - Escherichia coli and MSSA urinary tract infections: Carbapenem de-escalation challenges and outcomes
Rana K Abu-Farha, Lobna Gharaibeh, Rama Alkhawaldeh, Khawla Abu Hammour, Ammena Y Binsaleh, Sireen A Shilbayeh, Fahmi Y Al-Ashwal
Electronic Journal of General Medicine, 2025
This retrospective study evaluated carbapenem de-escalation in urinary tract infection patients with <i>Escherichia coli </i>(<i>E. coli</i>) or Methicillin-sensitive Staphylococcus aureus (MSSA) at Jordan University Hospital from January 2019 to July 2021. Among 398 patients who received empiric carbapenem therapy, 94 (23.6%) had positive urine cultures. Specifically, 67 patients had <i>E. coli</i>, 11 had MSSA, and 16 had both pathogens, with most (83%) having infections with a single organism. Only 9.6% of patients underwent successful de-escalation to a narrower-spectrum antibiotic within 48 hours of culture results, while 2.1% were incorrectly de-escalated. Interestingly, those who were successfully de-escalated had a longer median hospital stay (27 days, inter-quartile range [IQR] = 24) compared to those who failed or were incorrectly de-escalated (median = 9 days, IQR = 10) (p = 0.004). The low rate of de-escalation may reflect physicians’ reluctance to switch from broad-spectrum to narrow-spectrum antibiotics. Additionally, the longer hospital stays associated with successful de-escalation suggest the presence of underlying clinical factors influencing physicians’ behavior. - Prevalence, Appropriateness, and Outcomes of Colistin Use in Multidrug-Resistant Pseudomonas aeruginosa Infections: Insights from Hospital Data
Rana K. Abu-Farha, Savana Sobh, Khawla Abu Hammour, Feras Darwish El-Hajji, Sireen A. Shilbayeh, Rania Itani
Medicina Lithuania, 2025
Background and Objectives: This study aimed to assess the prevalence of colistin prescriptions among patients with multidrug-resistant (MDR) Pseudomonas aeruginosa (P. aeruginosa) infections admitted to a tertiary teaching hospital in Jordan. Additionally, the study evaluated the appropriateness of colistin prescriptions and assessed resistance levels of this strain. Materials and Methods: In this retrospective study, adult patients who were infected with MDR P. aeruginosa and were admitted to Jordan University Hospital between January 2018 and March 2024 were included. Data on demographics, clinical characteristics, sources of infection, antibiotic therapy, and clinical outcomes were collected. Results: Out of the 85 patients who met the inclusion criteria for having MDR P. aeruginosa, colistin was administered to 16 patients (18.8%). Notably, approximately two-thirds (68.7%) of the isolates from patients who received colistin were classified as extensively drug-resistant (XDR). Among the isolates, 15 out of 16 (93.8%) were resistant to both ciprofloxacin and imipenem. Among the patients requiring colistin, five (31.3%) discontinued therapy, while two (12.5%) remained on colistin despite the availability of safer alternatives. No significant difference was observed in 30-day all-cause mortality between patients treated with colistin (0%) and those who were not (4.3%, p = 1.00). Similarly, the incidence of acute kidney injury did not differ significantly between the colistin group (0%) and the non-colistin group (p = 1.00). No significant difference was found in the hospital stay between colistin-treated patients (median 10.5 days, IQR [5.0–14.0]) and those not treated with colistin (median 13.0 days, IQR [7.0–21.0]), (p = 0.22). Conclusions: This study demonstrated that colistin was selectively initiated in high-risk patients, particularly those with XDR P. aeruginosa. However, its inappropriate continuation despite safer alternatives, as well as its discontinuation when no other options existed, raise concerns about antibiotic de-escalation practices. Interestingly, no significant differences in mortality or acute kidney injury were observed between patients who were treated with colistin and those who were not. These findings emphasize the need for antimicrobial stewardship programs and highlight the importance of large-scale trials to evaluate colistin’s efficacy and safety in MDR infections. - Exploring Antibiotic Resistance Patterns in Escherichia coli Isolates from Urinary Tract Infections: A Retrospective Study
Rama Alkhawaldeh, Lobna Gharaibeh, Amer Hayat Khan, Khawla Abu Hammour, Mohammed Zawiah, Sireen AR. Shilbayeh, Rana K. Abu-Farha
Journal of Clinical Medicine, 2025
Objectives: This retrospective analysis was conducted to update the antibiotic sensitivity profiles of Escherichia coli (E. coli) in urinary tract infections (UTIs) among adults (≥18 years) in Jordan. Methods: Data were collected from patients diagnosed with UTIs and confirmed by positive E. coli cultures between 1 January 2019 and 9 July 2021. The resistance patterns of E. coli to empiric antibiotics were assessed by matching the prescribed antibiotics with those tested, using clinical breakpoints to classify isolates as susceptible or resistant. Results: During the study, 230 patients with urine cultures confirming E. coli infection were included. Empiric antibiotics were prescribed to 87.4% (n = 201) of patients. Sensitivity testing was performed for 136 patients (59.1%), revealing that 62 patients (27%) had E. coli strains resistant to at least one antibiotic. Among the 236 empiric antibiotics prescribed, the appropriateness of 72 agents (30.5%) could not be determined owing to the absence of sensitivity testing. The culture results indicate that eight antibiotics (3.3%) did not provide adequate coverage against E. coli. Of the remaining 156 agents (66.1%) subjected to sensitivity testing, 89 (37.7%) were effective, while 67 (28.3%) were ineffective owing to bacterial resistance. Patients who underwent sensitivity tests performed had significantly longer hospital stays (10 days) than those who did not (8 days; p = 0.032). Female patients had a higher proportion of resistant E. coli isolates (51.5%) compared to males (30.8%, p = 0.036). Conclusions: This study highlights the importance of ongoing surveillance to guide empiric therapy and promote appropriate antibiotic use. Tailoring treatment based on patient-specific factors is essential to effectively managing antimicrobial resistance and improving clinical outcomes. - Evaluation of empiric therapy appropriateness, resistance patterns, and mortality in Pseudomonas aeruginosa infections in Jordan
Savana Sobh, Rania Itani, Khawla Abu Hammour, Rana K. Abu-Farha
Exploration of Medicine, 2025
Aim: This study aimed to investigate the susceptibility patterns of Pseudomonas aeruginosa strains, examine infection characteristics, and evaluate the appropriateness of empiric antibiotic therapy. Additionally, the study sought to identify factors influencing 30-day all-cause mortality in patients with Pseudomonas aeruginosa infections. Methods: This was a retrospective study conducted at Jordan University Hospital from January 2018 to March 2024. Adult patients (≥ 18 years) with confirmed Pseudomonas aeruginosa infections were included. Data were collected from medical records, focusing on demographics, infection characteristics, antibiotic treatment, and outcomes. The susceptibility patterns of Pseudomonas aeruginosa isolates were classified as multidrug-resistant (MDR) or non-MDR. Logistic regression was used to identify factors associated with 30-day mortality. Results: A total of 210 patients were included in the study, with 106 males (50.5%) and 104 females (49.5%). The majority of infections were community-acquired (n = 178, 84.8%), with the respiratory tract being the most common infection site (n = 81, 38.6%). Nearly half of the Pseudomonas aeruginosa isolates were MDR (n = 99, 47.1%). Empiric antibiotic therapy was administered to all patients, with imipenem-cilastatin (55.7%), vancomycin (35.7%), and piperacillin-tazobactam (26.7%) being the most commonly used antibiotics. Of the 210 patients, 32.4% (n = 68) received inappropriate empiric therapy. The 30-day all-cause mortality rate was 4.9% (n = 10). Multivariate analysis revealed that non-localized infections, such as bacteremia and sepsis, were strongly associated with increased mortality [adjusted odds ratio (AOR) = 17.455, P < 0.001]. Conclusions: This study highlights the high prevalence of MDR Pseudomonas aeruginosa infections, especially in community-acquired cases, and emphasizes the need for improved antimicrobial stewardship. The significant proportion of patients (32.4%) receiving inappropriate empiric therapy calls for better guidance in antibiotic prescribing practices. The key predictor of mortality was infection localization, indicating the importance of early intervention for systemic infections to reduce mortality rates. - Effectiveness of fluoroquinolone de-escalation in community-acquired pneumonia: impact on hospital stay and mortality
Aseel Abu Awad, Khawla Abu Hammour, Alaa Abuawad, Mohammed Zawiah, Rana K. Abu-Farha
Exploration of Medicine, 2025 - A systematic review of vedolizumab in treating pediatric ulcerative colitis: efficacy and safety insights
Khawla Abu Hammour, Adnan Abu Hamour, Faris El-Dahiyat, Mohammed Zawiah, Rana K. Abu-Farha
Therapeutic Advances in Gastroenterology, 2025 - Knowledge, attitude, and perception regarding the respiratory syncytial virus vaccine among healthcare professionals
Khawla Abu Hammour, Qusai Al Manaseer, Mariam Abdel-Jalil, Faris El-dahiyat, Walid Abu Hammour, Adnan M. Abu Hammour, Fahmi Y. Al-Ashwal, Rana Abu-Farha
Journal of Pharmaceutical Policy and Practice, 2025 - Treatment-related problems in neonates receiving parenteral nutrition: risk factors and implications for practice
Amal Akour, Lobna Gharaibeh, Omar El Khatib, Khawla Abu Hammour, Noor AlTaher, Salah AbuRuz, Muna Barakat
BMC Pediatrics, 2024 - Assessment of adherence to the Infectious Diseases Society of America guidelines for treating suspected meningitis in adults: A retrospective observational study
Dina Mohialdin, Rana Abu-Farha, Rama ALkhawaldeh, Fahmi Y Al-Ashwal, Khawla Abu Hammour
Journal of Pharmaceutical Health Services Research, 2024 - Machine learning assessment of vildagliptin and linagliptin effectiveness in type 2 diabetes: Predictors of glycemic control
Hanin A. Esaifan, Loai M. Saadah, Khawla Abu Hammour, Rana K. Abu Farha
Plos One, 2024 - Impact of COVID-19 on asthma and COPD patients’ hospital care: a lesson for future pandemics
Oriana Awwad, Suha AlMuhaissen, Mariam Abdel Jalil, Zaina Battah, Khawla Abu Hammour, Saja Almonayer
Journal of Pharmaceutical Health Services Research, 2024 - Hospital pharmacists’ knowledge, attitudes and practice of pharmaceutical care and the barriers for its implementation at the hospital setting
Anan S. Jarab, Suhaib Muflih, Rawan Almomani, Shrouq Abu Heshmeh, Khawla Abu Hammour, Tareq L. Mukattash, Walid Al-Qerem, Eman A. Alefishat
Heliyon, 2024 - Audit of adherence to international guidelines (IDSA) in the treatment of infectious meningitis in pediatric patients in Jordan
Dina Mohialdin, Rana Abu-Farha, Rama ALkhawaldeh, Mohammed Zawiah, Khawla Abu Hammour
Current Medical Research and Opinion, 2024 - Occurrence and types of drug errors in voluntary reported incidents at a tertiary hospital in Jordan
Pharmacy Practice, 2024 - Cost-effectiveness of intravenous resuscitation fluids in sepsis patients: a patient-level data analysis in Jordan
Shoroq M. Altawalbeh, Eman M. Almestarihi, Rawand A. Khasawneh, Suleiman M. Momany, Khawla Abu Hammour, Mohammad S. Shawaqfeh, Ivo Abraham
Journal of Medical Economics, 2024 - A retrospective analysis of the pharmacovigilance data registry in a tertiary teaching hospital in Jordan
Khawla Abu Hammour, Faris El-Dahiyat, Rund Hyari, Sara Salameh, Qusai Manaseer, Rana Abu Farha, Adnan Abu Hammour, Mohammed Zawiah
Journal of Pharmaceutical Policy and Practice, 2024 - Knowledge, perception, and practice of health professions students and academics regarding halal pharmaceuticals: A cross-sectional study
Deema Jaber, Samaa Akram Al Tabbah, Lina Elsalem, Ahlam Zaid Alkilani, Eman Bani Omar, Khawla Abu Hammour, Hisham E. Hasan, Nadeem Salman
Journal of Infrastructure Policy and Development, 2024 - Detecting manuscripts written by generative AI and AI-assisted technologies in the field of pharmacy practice
Ammar Abdulrahman Jairoun, Faris El-Dahiyat, Ghaleb A. ElRefae, Sabaa Saleh Al-Hemyari, Moyad Shahwan, Samer H. Zyoud, Khawla Abu Hammour, Zaheer-Ud-Din Babar
Journal of Pharmaceutical Policy and Practice, 2024 - Exploring Jordanian medical students’ perceptions and concerns about ChatGPT in medical education: a cross-sectional study
Adnan Abu Hammour, Khawla Abu Hammour, Hamza Alhamad, Razan Nassar, Faris El-Dahiyat, Majd Sawaqed, Aya Allan, Qusai Manaseer, Mohammad Abu Hammour, Abdulsalam Halboup, Rana Abu Farha
Journal of Pharmaceutical Policy and Practice, 2024 - Correlation of vitamin D receptor genotypes, specific IgE levels and other variables with asthma control in children
Walid Al-Qerem, Anan Jarab, Yazun Jarrar, Enas Al-Zayadneh, Montaha Al-Iede, Jonathan Ling, Khawla Abu Hammour, Sally S. Alabdullah, Asal Saad Alabdullah, Yamam Al Refaie, Dina Lubbad, Ameen Alassi, Sarah Ibrahim, Mahmood Al-Ibadah, Abdel Qader Al Bawab
Journal of Asthma, 2024 - ChatGPT in pharmacy practice: a cross-sectional exploration of Jordanian pharmacists' perception, practice, and concerns
Khawla Abu Hammour, Hamza Alhamad, Fahmi Y. Al-Ashwal, Abdulsalam Halboup, Rana Abu Farha, Adnan Abu Hammour
Journal of Pharmaceutical Policy and Practice, 2023 - The impact of educational interventional session on healthcare providers knowledge about pharmacovigilance at a tertiary Jordanian teaching hospital
Faris El-Dahiyat, Khawla Abu Hammour, Rana Abu Farha, Qusai Manaseer, Ala’a Momani, Aya Allan
Journal of Pharmaceutical Policy and Practice, 2023 - Correction: ChatGPT in pharmacy practice: a cross-sectional exploration of Jordanian pharmacists’ perception, practice, and concerns (Journal of Pharmaceutical Policy and Practice, (2023), 16, 1, (115), 10.1186/s40545-023-00624-2)
Khawla Abu Hammour, Hamza Alhamad, Fahmi Y. Al-Ashwal, Abdulsalam Halboup, Rana Abu Farha, Adnan Abu Hammour
Journal of Pharmaceutical Policy and Practice, 2023 - The prevalence of Carbapenem Resistance Gram negative pathogens in a Tertiary Teaching Hospital in Jordan
Khawla Abu Hammour, Rana Abu-Farha, Rania Itani, Samar Karout, Aya Allan, Qusai Manaseer, Walid Abu Hammour
BMC Infectious Diseases, 2023 - Jordanians' knowledge, attitude and practice regarding adverse drug reactions reporting
Faris El-Dahiyat, Khawla Abu Hammour, Rana Abu Farha, Qusai Manaseer, Ala'a Al Momanee, Aya Allan, Rama Alkhawaldeh
Saudi Pharmaceutical Journal, 2023 - Vancomycin audit in the paediatric population: Patterns of use and appropriateness of therapeutic drug monitoring
Mariam Abdel Jalil, Farah Khaled, Farah Qaryouti, Khawla Abu Hammour, Mervat Alsous, Montaha Al‐Iede
Basic and Clinical Pharmacology and Toxicology, 2023 - Vancomycin prescribing and therapeutic drug monitoring: Challenges of real clinical practice
Mariam Hantash Abdel Jalil, Rima Ηijazeen, Farah Khaled Abu-Mahfouz, Khawla Abu Hammour, Maria Hasan Matalqah, Jwan Saleh Khaleel Albadaineh, Shrouq Khaled AlOmoush, Montaha Al-Iede
Plos One, 2023 - Diagnosis and treatment of stroke associated pneumonia: Qualitative exploration of clinicians’ practice
Mohammed Zawiah, Amer Hayat Khan, Rana Abu Farha, Abubakar Usman, Abubakar Sha’aban, Khawla Abu Hammour, Zahraa Almuhsen
Electronic Journal of General Medicine, 2023 - ChatGPT and Clinical Training: Perception, Concerns, and Practice of Pharm-D Students
Mohammed Zawiah, Fahmi Al-Ashwal, Lobna Gharaibeh, Rana Abu Farha, Karem Alzoubi, Khawla Abu Hammour, Qutaiba A Qasim, Fahd Abrah
Journal of Multidisciplinary Healthcare, 2023 - Optimizing antimicrobial therapy in urinary tract infections: A focus on urine culture and sensitivity testing
Rama Alkhawaldeh, Rana Abu Farha, Khawla Abu Hammour, Eman Alefishat
Frontiers in Pharmacology, 2022 - Evaluation of drug use pattern in adults' outpatient clinics in a tertiary teaching hospital using WHO core prescribing indicators
Rana Abu Farha, Oriana Awwad, Bashar Abdurazaq, Khawla Abu Hammour, Amal Akour
Journal of Pharmaceutical Health Services Research, 2022 - Capacity Building for Health Technology Assessment in Jordan: Institutionalization and Its Use in Pricing and Reimbursement Decisions
Emad Almomani, Eman A. Hammad, Raeda AlQutob, Khawla Abu Hammour, Emad Al-Sharu, Muien Abu-Shaer, Ibrahim Alabbadi, Zoltán Kaló
Value in Health Regional Issues, 2022 - Detection of medication administration errors at a tertiary hospital using a direct observation approach
Alaa M. Yousef, Rana K. Abu-Farha, Khawla M. Abu-Hammour
Journal of Taibah University Medical Sciences, 2022 - Impact of Pharmacist-Directed Medication Reconciliation in Reducing Medication Discrepancies: A Randomized Controlled Trial
Khawla Abu Hammour, Rana Abu Farha, Rawan Ya’acoub, Zeinab Salman, Iman Basheti
Canadian Journal of Hospital Pharmacy, 2022 - Is COVID-19 multisystem inflammatory syndrome a new variant of Kawasaki Disease?
Khawla Abu Hammour, Rana Abu Farha, Qusai Manaseer, Tasnim Dawoud, Walid Abu Hammour
Archives of Rheumatology, 2022 - The Appropriateness of Empiric Treatment of Urinary Tract Infections in a Tertiary Teaching Hospital in Joran: A Cross-Sectional Study
Rama Alkhawaldeh, Rana Abu Farha, Khawla Abu Hammour, Eman Alefishat
Antibiotics, 2022 - Genetic and Clinical Characteristics of Patients in the Middle East With Multisystem Inflammatory Syndrome in Children
Walid Abuhammour, Lemis Yavuz, Ruchi Jain, Khawla Abu Hammour, Ghalia F. Al-Hammouri, Maha El Naofal, Nour Halabi, Sawsan Yaslam, Sathishkumar Ramaswamy, Alan Taylor, Deena Wafadari, Ali Alsarhan, Hamda Khansaheb, Zulfa Omar Deesi, Rupa Murthy Varghese, Mohammed Uddin, Hanan Al Suwaidi, Suleiman Al-Hammadi, Abdulmajeed Alkhaja, Laila Mohamed AlDabal, Tom Loney, Norbert Nowotny, Abdulla Al Khayat, Alawi Alsheikh-Ali, Ahmad Abou Tayoun
JAMA Network Open, 2022 - Jordanian experience: The internet pharmacy drug delivery platform during the COVID-19
Khawla Abu Hammour, Mariam Abdeljalil, Qusai Manaseer, Bayan Al-Manaseer
Health Policy and Technology, 2022 - Perceived Public Stress Among Jordanians During the COVID-19 Outbreak
Mariam H. Abdel Jalil, Mervat M. Alsous, Eman A. Hammad, Rimal Mousa, Mais M. Saleh, Khawla Abu Hammour
Disaster Medicine and Public Health Preparedness, 2022 - Factors affecting the public's knowledge about COVID-19 vaccines and the influence of knowledge on their decision to get vaccinated
Khawla Abu Hammour, Rana Abu Farha, Qusai Manaseer, Bayan Al-Manaseer
Journal of the American Pharmacists Association, 2022 - Impact of Distance Learning on Pharmacy and Pharm.D Undergraduates’ during the COVID-19 Pandemic in Jordan
Anan S. Jarab, Walid Al-Qerem, Tareq L. Mukattash, Douaa Al-Hajjeh, Ahmed Al-Azayzih, Khawla Abu Hammour
Jordan Journal of Pharmaceutical Sciences, 2022 - Evaluation of Drug Use Pattern in Pediatric Outpatient Clinics in a Tertiary Teaching Hospital Using WHO Drug-Prescribing Indicators
Aya Aldabagh, Rana Abu Farha, Samar Karout, Rania Itani, Khawla Abu Hammour, Eman Alefishat
Journal of Multidisciplinary Healthcare, 2022 - Potential prescribing omissions of medications in older adults based on START version 2 criteria in a tertiary Jordanian teaching hospital
Khawla Abu Hammour,, Mariam Abdeljalil, Rana Abu Farha, Sara Alhabeis, Qusai Manaseer, Samah AbuMoghli
Journal of Applied Pharmaceutical Science, 2021 - Hospital staff perspectives: Medication reconciliation responsibility and barriers at a tertiary teaching hospital in Jordan
Seliman M Ibrahim, Khawla Abu Hamour, Farah Abu Mahfouz, Mariam H Abdel Jalil, Eman A Hammad
Journal of Pharmaceutical Health Services Research, 2021 - Medication discrepancies in hospitalized cancer patients: Do we need medication reconciliation?
Maram Abu Moghli, Rana Abu Farha, Khawla Abu Hammour
Journal of Oncology Pharmacy Practice, 2021 - Population Pharmacokinetic Studies of Digoxin in Adult Patients: A Systematic Review
Mariam Abdel Jalil, Noura Abdullah, Mervat Alsous, Khawla Abu-Hammour
European Journal of Drug Metabolism and Pharmacokinetics, 2021 - Prevalence and predictors of polypharmacy in Jordanian hospitalised patients: A cross-sectional Study
Rana K. Abu Farha, Tareq L. Mukattash, Lina Al‐Sakran, Khawla Abu Hammour, Mohammed Zawiah
International Journal of Clinical Practice, 2021 - Prevalence of potentially inappropriate prescribing in older adults in Jordan: Application of the STOPP criteria
Khawla Abu Hammour, Mariam Abdel jalil, Sara AlHabeis, Ghayda' Abu Hammour, Qusai Manaseer
Australasian Journal on Ageing, 2021 - Role of Pharmacists in COVID-19 Disease: A Jordanian Perspective
Mariam Abdel Jalil, Mervat M Alsous, Khawla Abu Hammour, Mais M Saleh, Rimal Mousa, Eman A Hammad
Disaster Medicine and Public Health Preparedness, 2020 - Evaluation of the completeness of information sources used to prepare the best possible medication histories at a tertiary teaching hospital in Jordan
Nadeen Asakrh, Rana Abu Farha, Khawla Abu Hammour, Amna Al‐Hashar
International Journal of Clinical Practice, 2020 - Antimicrobial consumption and resistance in a tertiary care hospital in Jordan: Results of an internet-based global point prevalence survey
Khawla Abu Hammour, Esraa AL-Heyari, Aya Allan, Ann Versporten, Herman Goossens, Ghayda’ Abu Hammour, Qusai Manaseer
Antibiotics, 2020 - A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population
Mariam H. Abdel Jalil, Noura Abdullah, Mervat M. Alsous, Mohammad Saleh, Khawla Abu‐Hammour
British Journal of Clinical Pharmacology, 2020 - Influencing factors of knowledge, attitude, and practice regarding antibiotic use in children with upper respiratory tract infections in Dubai
Samar Al‐Saleh, Khawla Abu Hammour, Walid Abu Hammour
Journal of Evaluation in Clinical Practice, 2020 - Medication histories documentation at the community pharmacy setting: A study from Jordan
Rana Abu Farha, Khawla Abu Hammour, Tareq Mukattash, Raja Alqudah, Rand Aljanabi
Plos One, 2019 - Parental views of antibiotic use in children with upper respiratory tract infections in Dubai
Khawla Abu Hammour, Samar Al-Saleh, Walid Abu Hammour
European Journal of Integrative Medicine, 2019 - Impact of pharmacist's directed medication reconciliation on reducing medication discrepancies during transition of care in hospital setting
Lana K. Salameh, Rana K. Abu Farha, Khawla M. Abu Hammour, Iman A. Basheti
Journal of Pharmaceutical Health Services Research, 2019 - Pharmacy drive-thru service in Jordan: assessing customers' awareness, perceptions and factors affecting the use of this service
Khawla Abu Hammour, Rana Abu Farha, Mai Rizik, Tareq Mukattash, Murhaf Alnan, Ahmad Alkhader, Rand Aljanabi, Iman Basheti
Journal of Pharmaceutical Health Services Research, 2019 - The prevalence and clinical seriousness of medication discrepancies identified upon hospital admission of pediatric patients
Rana Abu Farha, Khawla Abu Hammour, Sayida Al-Jamei, Raja AlQudah, Mohammed Zawiah
BMC Health Services Research, 2018 - An exploration of parents’ knowledge, attitudes and practices towards the use of antibiotics in childhood upper respiratory tract infections in a tertiary Jordanian Hospital
Khawla Abu Hammour, Mariam Abdel Jalil, Walid Abu Hammour
Saudi Pharmaceutical Journal, 2018 - Effect of educational intervention on healthcare providers knowledge and perception towards pharmacovigilance: A tertiary teaching hospital experience
Rana Abu Farha, Khawla Abu Hammour, Mai Rizik, Rand Aljanabi, Lina Alsakran
Saudi Pharmaceutical Journal, 2018 - Evaluation of risk factors affecting parental knowledge and attitude toward antibiotic use in children with upper respiratory tract infections
Khawla Abu Hammour, Rana Abu Farha, Mervat Alsous, Mai Rizik, Walid Abu Hammour
European Journal of Integrative Medicine, 2018 - Noncompliance with surgical antimicrobial prophylaxis guidelines: A Jordanian experience in cesarean deliveries
Mariam Hantash Abdel Jalil, Khawla Abu Hammour, Mervat Alsous, Rand Hadadden, Wedad Awad, Faris Bakri, Kamil Fram
American Journal of Infection Control, 2018 - Drive-thru pharmacy service: Assessments of awareness, perception and barriers among pharmacists in Jordan
Rana Abu Farha, Khawla Abu Hammour, Eman Alefishat, Hiba Alsaeed, Sajida Alma'aiah
Saudi Pharmaceutical Journal, 2017 - Surgical site infections following caesarean operations at a Jordanian teaching hospital: Frequency and implicated factors
Mariam Hantash Abdel Jalil, Khawla Abu Hammour, Mervat Alsous, Wedad Awad, Rand Hadadden, Faris Bakri, Kamil Fram
Scientific Reports, 2017 - Health care professionals knowledge and perception of pharmacovigilance in a tertiary care teaching hospital in Amman, Jordan
Khawla Abu Hammour, Faris El-Dahiyat, Rana Abu Farha
Journal of Evaluation in Clinical Practice, 2017 - Hospital pharmacy medication reconciliation practice in Jordan: perceptions and barriers
Khawla Abu Hammour, Rana Abu Farha, Iman Basheti
Journal of Evaluation in Clinical Practice, 2016 - Medication errors in voluntary reported incidents at a Jordanian hospital
Khawla Abu Hammour, Mariam H. Abdel Jalil
Jordan Medical Journal, 2016
